Protecting a blockbuster diabetes treatment for AstraZeneca
AstraZeneca AB
Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini
Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.
No confusion in trademark victory on summary judgment for the American Retirement Association
American Retirement Association
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Finnegan secures favorable ITC ruling related to innovative electric SUVs for BMW
BMW of North America, LLC and Bayerische Motoren Werke AG
Finnegan fights for Sony’s “exceedingly famous” mark
Sony Group Corporation
Experience
Bial - Portela & CA S.A. v. Alkem Laboratories Ltd et al. Bial - Portela & CA S.A. v. Alkem Laboratories Ltd et al.
1:18-cv-00304, D. Del., Judges Connolly, Burke
Experience
Certain Solid State Storage Drives, Stacked Electronics Components, and Products Containing Same Certain Solid State Storage Drives, Stacked Electronics Components, and Products Containing Same
337-TA-1097, ITC, Judge Lord
Experience
Biogen International GmbH v. Teva Pharmaceuticals USA, Inc. Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.
1:17-cv-00829, D. Del., Judge Noreika
1:17-cv-00116, N.D.W. Va., Judge Keeley
Experience
Flexsys America L.P. v. Process Engineering Associates LLC Flexsys America L.P. v. Process Engineering Associates LLC
3:16-cv-00311, E.D. Tenn., Judges Mattice, Guyton
Experience
Otsuka Pharmaceutical Co., Ltd. v. Apotex Corp. Otsuka Pharmaceutical Co., Ltd. v. Apotex Corp.
1:14-cv-01078, -04671, -02982, -07405, -05878, -06398 -08074 -03306, -06890, -05876, -08077, -03168, -07252, -07105 -05537, -03996, -06158, -04508, -04307, -06397, -07106, -01979, -03445; 1:15-cv-0161, -07584, -01585, -07803, -08830, -05109, -07802, -08955, -01716, -01967, -06353, -08305; 1:16-cv-05288, -05400, -05949, -07705 -02475, -02476, -08284, -05743, -00086, -08085, -00555, -00557, -07346, -06067, -00405, -00424, -05688, -09603; 1:17-cv-02754, -00392, D.N.J., Judges Simandle, Williams
Experience
Certain Krill Oil Products and Krill Meal for Production of Krill Oil Certain Krill Oil Products and Krill Meal for Production of Krill Oil
337-TA-1019, ITC, Judge Lord
Experience
Certain Computing Devices with Associated Instruction Sets and Software Certain Computing Devices with Associated Instruction Sets and Software
337-TA-812, ITC, Judge Pender
Experience
Global litigation strategy results in global settlement Global litigation strategy results in global settlement
337-TA-802, ITC, Judge Rogers
337-TA-784, ITC, Judges Essex, Shaw
337-TA-785, ITC, Judges Bullock, Pender
1:11-cv-00660, D. Del., Judges Andrews, Joyner
4:11-cv-02699, N.D. Cal., N.D. Cal., Judges Hamilton, James
Experience
District court grants summary judgment in favor of AstraZeneca finding invalid all asserted claims against anti-cholesterol drug Crestor® District court grants summary judgment in favor of AstraZeneca finding invalid all asserted claims against anti-cholesterol drug Crestor®
2:08-cv-04786, E.D. Pa., Judge Yohn
11-1091, Fed. Cir., Judges Dyk, Linn, Rader
Experience
District court ruling maintains patent and regulatory protection of Otsuka’s Abilify® District court ruling maintains patent and regulatory protection of Otsuka’s Abilify®
3:07-cv-01000, D.N.J., Judges Cooper, Goodman, Hughes
11-1126, -1127, Fed. Cir., Judges Lourie, Moore, Reyna
Experience
Honeywell loses decision in GPS fight with Pioneer Honeywell loses decision in GPS fight with Pioneer
337-TA-657, ITC, Judge Essex
Experience
Certain Pesticides and Products Containing Clothianidin Certain Pesticides and Products Containing Clothianidin
337-TA-635, ITC, Judge Bullock
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.